Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Suspended × Liver Neoplasms × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Completed 7 Unknown 3 Terminated 3 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Liver Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Agnosia 1 Adenocarcinoma of Lung 1

Interventions

lenvatinib 1 Sorafenib 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05033522 2025-10-23

ALIVE

Mirror Biologics, Inc.

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡